{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-221209","form_type":"8-K","ticker":"ACLX","cik":"0001786205","company_name":"Arcellx, Inc.","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.029015+00:00","generated_at":"2026-06-23T23:59:20.806890+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arcellx Q2 net loss $32.1M; cash $307M; CART-ddBCMA shows 100% ORR","bullets":["Net loss $32.1M vs $15.9M YoY; R&D spend $23.4M; G&A $9.2M.","Cash, equivalents & securities $307.0M as of June 30, 2022, funding operations for at least 12 months.","Completed $128.8M follow-on offering (8.05M shares at $16.00).","CART-ddBCMA Phase 1: 100% ORR, 71% CR/sCR in r/r MM; no Grade ≥3 CRS at 100M CAR+ cells.","Appointed Michelle Gilson as CFO and Maryam Abdul-Kareem as General Counsel."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-221209","json":"https://secwatch.observer/filing/0001193125-22-221209.json","markdown":"https://secwatch.observer/filing/0001193125-22-221209.md","text":"https://secwatch.observer/filing/0001193125-22-221209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1786205/000119312522221209/0001193125-22-221209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1786205/000119312522221209/d256519d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:59:20.806890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}